Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported in the Condensed Consolidated Balance Sheet to the total amounts in the Condensed Consolidated Statement of Cash Flows as follows:

	June 30, 2020		June 30, 2019
Cash and cash equivalents	$	5,851	$	4,121
Restricted cash	206		206
Restricted cash in other assets	468		472
Cash, cash equivalents and restricted cash in the statement of cash flows	$	6,525	$	4,799

Schedule of Earnings Per Share, Basic and Diluted

For the three and six months ended June 30, 2020, the potential dilutive common stock equivalents have been excluded from the computation of diluted loss per share, as their effect would have been anti-dilutive.

In accordance with ASC 260-10-45-13, the Company included the Warrants issued to its Term Loan lenders to purchase 538,995 shares of the Company’s common stock at an exercise price of $0.01 per share (Note 7), from May 28, 2020 to June 30, 2020, in the number of outstanding shares used to calculate the basic and diluted loss per share for the three and six months ended June 30, 2020.

(in thousands except shares and per share data) 

	Three months ended June 30,				Six months ended June 30,
	2020		2019		2020		2019
Basic loss per share computation:
Net loss - basic and diluted	$	(14,332)	$	(3,989)	$	(41,168)	$	(12,713)
Weighted average common shares - basic and diluted	5,593,557		5,384,909		5,491,554		5,382,764
Basic and diluted loss per share	$	(2.56)	$	(0.74)	$	(7.50)	$	(2.36)